Skip to main content
×
Home
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 19
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Julien, Michelle Wild, Jeffrey L. Blansfield, Joseph Shabahang, Mohsen Halm, Kristen Meade, Paul Dove, James Fluck, Marcus Hunsinger, Marie and Leonard, Diane 2016. Severe complicated Clostridium difficile infection. Journal of Trauma and Acute Care Surgery, Vol. 81, Issue. 2, p. 221.


    Jump, Robin L. P. and Donskey, Curtis J. 2015. Clostridium difficile in the Long-Term Care Facility: Prevention and Management. Current Geriatrics Reports, Vol. 4, Issue. 1, p. 60.


    Kociolek, Larry K. Patel, Sameer J. Shulman, Stanford T. and Gerding, Dale N. 2015. Molecular Epidemiology of Clostridium difficile Infections in Children: A Retrospective Cohort Study. Infection Control & Hospital Epidemiology, Vol. 36, Issue. 04, p. 445.


    Marsh, Jane W. and Harrison, Lee H. 2015. Antimicrobial Resistance and Food Safety.


    Scardina, T. Labuszewski, L. Pacheco, S.M. Adams, W. Schreckenberger, P. and Johnson, S. 2015. Clostridium difficile Infection (CDI) Severity and Outcome among Patients Infected with the NAP1/BI/027 Strain in a Non-Epidemic Setting. Infection Control & Hospital Epidemiology, Vol. 36, Issue. 03, p. 280.


    Dubberke, Erik R. Carling, Philip Carrico, Ruth Donskey, Curtis J. Loo, Vivian G. McDonald, L. Clifford Maragakis, Lisa L. Sandora, Thomas J. Weber, David J. Yokoe, Deborah S. and Gerding, Dale N. 2014. Strategies to Prevent Clostridium difficile Infections in Acute Care Hospitals: 2014 Update. Infection Control & Hospital Epidemiology, Vol. 35, Issue. 06, p. 628.


    Dubberke, Erik R. Carling, Philip Carrico, Ruth Donskey, Curtis J. Loo, Vivian G. McDonald, L. Clifford Maragakis, Lisa L. Sandora, Thomas J. Weber, David J. Yokoe, Deborah S. and Gerding, Dale N. 2014. Strategies to Prevent Clostridium difficile Infections in Acute Care Hospitals: 2014 Update. Infection Control & Hospital Epidemiology, Vol. 35, Issue. S2, p. S48.


    Dubberke, Erik R. Carling, Philip Carrico, Ruth Donskey, Curtis J. Loo, Vivian G. McDonald, L. Clifford Maragakis, Lisa L. Sandora, Thomas J. Weber, David J. Yokoe, Deborah S. and Gerding, Dale N. 2014. Strategies to PreventClostridium difficileInfections in Acute Care Hospitals: 2014 Update. Infection Control and Hospital Epidemiology, Vol. 35, Issue. 6, p. 628.


    Gerding, Dale N Johnson, Stuart Rupnik, Maja and Aktories, Klaus 2014. Clostridium difficilebinary toxin CDT. Gut Microbes, Vol. 5, Issue. 1, p. 15.


    Johnson, S. 2014. Editorial Commentary: Changing Epidemiology of Clostridium difficile and Emergence of New Virulent Strains. Clinical Infectious Diseases, Vol. 58, Issue. 12, p. 1731.


    Johnson, S. Louie, T. J. Gerding, D. N. Cornely, O. A. Chasan-Taber, S. Fitts, D. Gelone, S. P. Broom, C. and Davidson, D. M. 2014. Vancomycin, Metronidazole, or Tolevamer for Clostridium difficile Infection: Results From Two Multinational, Randomized, Controlled Trials. Clinical Infectious Diseases, Vol. 59, Issue. 3, p. 345.


    Eyre, David W and Walker, A Sarah 2013. Clostridium difficilesurveillance: harnessing new technologies to control transmission. Expert Review of Anti-infective Therapy, Vol. 11, Issue. 11, p. 1193.


    Halabi, Wissam J. Nguyen, Vinh Q. Carmichael, Joseph C. Pigazzi, Alessio Stamos, Michael J. and Mills, Steven 2013. Clostridium Difficile Colitis in the United States: A Decade of Trends, Outcomes, Risk Factors for Colectomy, and Mortality after Colectomy. Journal of the American College of Surgeons, Vol. 217, Issue. 5, p. 802.


    Hebert, Courtney Du, Hongyan Peterson, Lance R. and Robicsek, Ari 2013. Electronic Health Record–Based Detection of Risk Factors for Clostridium difficile Infection Relapse. Infection Control & Hospital Epidemiology, Vol. 34, Issue. 04, p. 407.


    Pacheco, Susan M. and Johnson, Stuart 2013. Important clinical advances in the understanding of Clostridium difficile infection. Current Opinion in Gastroenterology, Vol. 29, Issue. 1, p. 42.


    Sears, Pamela Ichikawa, Yoshi Ruiz, Nancy and Gorbach, Sherwood 2013. Advances in the treatment ofClostridium difficilewith fidaxomicin: a narrow spectrum antibiotic. Annals of the New York Academy of Sciences, Vol. 1291, Issue. 1, p. 33.


    Wang, Michael S. Evans, Charlesnika T. Rodriguez, Tulio Gerding, Dale N. and Johnson, Stuart 2013. Clostridium difficile Infection and Limitations of Markers for Severity in Patients with Hematologic Malignancy. Infection Control & Hospital Epidemiology, Vol. 34, Issue. 02, p. 127.


    Hall, A. J. Curns, A. T. McDonald, L. C. Parashar, U. D. and Lopman, B. A. 2012. The Roles of Clostridium difficile and Norovirus Among Gastroenteritis-Associated Deaths in the United States, 1999-2007. Clinical Infectious Diseases, Vol. 55, Issue. 2, p. 216.


    Petrella, L. A. Sambol, S. P. Cheknis, A. Nagaro, K. Kean, Y. Sears, P. S. Babakhani, F. Johnson, S. and Gerding, D. N. 2012. Decreased Cure and Increased Recurrence Rates for Clostridium difficile Infection Caused by the Epidemic C. difficile BI Strain. Clinical Infectious Diseases, Vol. 55, Issue. 3, p. 351.


    ×
  • Infection Control & Hospital Epidemiology, Volume 32, Issue 9
  • September 2011, pp. 897-902

Clostridium difficile Outbreak Strain BI Is Highly Endemic in Chicago Area Hospitals

  • Stephanie R. Black (a1), Kingsley N. Weaver (a1), Roderick C. Jones (a1), Kathleen A. Ritger (a1), Laurica A. Petrella (a2), Susan P. Sambol (a2), Michael Vernon (a3), Stephanie Burton (a4), Sylvia Garcia-Houchins (a4), Stephen G. Weber (a4), Mary Alice Lavin (a5), Dale Gerding (a2), Stuart Johnson (a2) and Susan I. Gerber (a3)
  • DOI: http://dx.doi.org/10.1086/661283
  • Published online: 02 January 2015
Abstract
Objective.

Describe the clinical and molecular epidemiology of incident Clostridium difficile infection (CDI) cases in Chicago area acute healthcare facilities (HCFs).

Design and Setting.

Laboratory, clinical, and epidemiologic information was collected for patients with incident CDI who were admitted to acute HCFs in February 2009. Stool cultures and restriction endonuclease analysis typing of the recovered C. difficile isolates was performed.

Patients.

Two hundred sixty-three patients from 25 acute HCFs.

Results.

Acute HCF rates ranged from 2 to 7 patients with CDI per 10,000 patient-days. The crude mortality rate was 8%, with 20 deaths occurring in patients with CDI. Forty-two (16%) patients had complications from CDI, including 4 patients who required partial, subtotal, or total colectomy, 3 of whom died. C. difficile was isolated and typed from 129 of 178 available stool specimens. The BI strain was identified in 79 (61%) isolates. Of patients discharged to long-term care who had their isolate typed, 36 (67%) had BI-associated CDI.

Conclusions.

Severe disease was common and crude mortality was substantial among patients with CDI in Chicago area acute HCFs in February 2009. The outbreak-associated BI strain was the predominant endemic strain identified, accounting for nearly two-thirds of cases. Focal HCF outbreaks were not reported, despite the presence of the BI strain. Transfer of patients between acute and long-term HCFs may have contributed to the high incidence of BI cases in this investigation.

Copyright
Corresponding author
2160 West Ogden Avenue, Chicago, IL 60612 (stephanie.black@cityofchicago.org)
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

5.VG Loo , L Poirier , MA Miller , et al.A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005;353:24422449.

6.J Pepin , L Valiquette , ME Alary , et al.Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ 2004;171:466472.

7.LC McDonald , GE Killgore , A Thompson , et al.An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005;353:24332441.

13.D Gravel , M Miller , A Simor , et al.Health care-associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: a Canadian nosocomial infection surveillance program study. Clin Infect Dis 2009;48:568576.

14.M Miller , D Gravel , M Mulvey , et al.Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality. Clin Infect Dis 2010;50:194201.

15.JR O'Connor , S Johnson , DN Gerding . Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain. Gastroenterology. 2009;136:19131924.

16.B Hubert , VG Loo , AM Bourgault , et al.A portrait of the geographic dissemination of the Clostridium difficile North American pulsed-field type 1 strain and the epidemiology of C. difficile-associated disease in Quebec. Clin Infect Dis 2007;44:238244.

17.EJC Goldstein , J Polonsky , M Touzani , DM Citron . C. difficile infection (CDI) in a long-term acute care facility (LTAC). Anaerobe 2009;15:241243.

19.AK Cheknis , SP Sambol , DM Davidson , et al.Distribution of Clostridium difficile strains from North America, European and Australian trial of treatment for C. difficile infections: 2005-2007. Anaerobe 2009;15:230233.

21.FA Zar , SR Bakkanagari , KM Moorthi , MB Davis . A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis 2007;45:302307.

22.ER Dubberke , AM Butler , KA Reske , et al.Attributable outcomes of endemic Clostridium difficile-associated disease in nonsurgical patients. Emerg Infect Dis 2008;14:10311038.

24.SV Kazakova , K Ware , B Baughman , et al.A hospital outbreak of diarrhea due to an emerging epidemic strain of Clostridium difficile. Arch Intern Med 2006;166:25182524.

26.S Johnson , C Schriever , M Galang , CP Kelly , DN Gerding . Interruption of recurrent Clostridium difficile-associated diarrhea episodes by serial therapy with vancomycin and rifaximin. Clin Infect Dis 2007;44:846848.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Infection Control & Hospital Epidemiology
  • ISSN: 0899-823X
  • EISSN: 1559-6834
  • URL: /core/journals/infection-control-and-hospital-epidemiology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×